Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial
Hoffmann-La Roche
Gerd R Burmester; Frank Buttgereit; Corrado Bernasconi; Jose M Álvaro-Gracia; Nidia Castro; Maxime Dougados; Cem Gabay; Jacob M van Laar; Jan Michael Nebesky; Attila Pethoe-Schramm; Carlo Salvarani; Marc Y Donath; Markus R John; SEMIRA collaborators